Big Pharma Embraces Longevity as Aging Becomes a Drug Target
For decades, the pharmaceutical industry treated aging as an inevitable backdrop to disease. Companies developed drugs for heart failure, diabetes,
Read more
Life
Senolytic Drugs and Rapamycin Trials Reshape Longevity Medicine in 2026
The landscape of longevity medicine has shifted dramatically in 2026, with two landmark clinical trials delivering results that move anti-aging
Read more
Rejuvenating Old Blood Stem Cells Could Rewrite the Future of Healthy Aging
For decades, the scientific community treated aging as an irreversible downward trajectory — a slow, inevitable decline that begins somewhere
Read more